# SEG Source Registry Closure Validation Report

**Mode:** `CONTROLLED READ-ONLY EVIDENCE CLOSURE REVIEW`  
**Input package:** `SEG_SOURCE_REGISTRY_EVIDENCE_CLOSURE_PACKAGE_v1.0.zip`  
**Package SHA-256:** `62bafb3662f9bf5308851b6334702f2233585621ee644b53d72037e54c9aab1e`  
**Package size:** 4,896 bytes  
**Package contents:** 11 Markdown members; no duplicate archive members and no zero-byte members were detected.  
**Report status:** `BLOCKED_PENDING_EVIDENCE`

## 1. Scope and decision boundary

This report validates **missing evidence only**. The package was inspected as a governance evidence bundle, not as a source-content payload. No medical content was normalized, rewritten, clinically judged, mapped, imported, or converted into production records. No database record, schema, SQL, seed, migration, Atlas record, content link, or activation was created.

The closure rule remains fail-closed: a source may not progress to `SEG_CONTENT_RECORD_V1_1`, adapter work, database storage, or learner exposure until source identity, version, checksum, provenance, rights, precise locator coverage, professional-track context, independent medical review, and audit evidence are available where required. The package itself states that closure is not complete and that evidence collection is the next phase. [1]

## 2. Package-level evidence inventory

The archive contains a README, a source-status table, an OSCE recovery request, source-closure notes for Drug HTML, HIPPO, FRCEM, and Oxford, a medical-review assignment template, a rights tracker, a final closure gate, and evidence-collection notes. These are governance notes and requests; they are not the underlying medical source artifacts or independent evidence records.

| Evidence category | Observed in package | Closure interpretation |
|---|---|---|
| Source status and named blockers | Present in `01_SOURCE_EVIDENCE_STATUS.md` | Useful inventory evidence; does not close any blocker. |
| Drug HTML file-level SHA and structural counts | Present in `03_DRUG_HTML_SOURCE_CLOSURE.md` | Confirms a checksum claim and observed counts; does not establish authoritative source identity, rights, or review. |
| OSCE recovery request | Present in `02_OSCE_ATLAS_RECOVERY_REQUEST.md` | Confirms the exact artifact requested and required metadata; the requested container and image members are not included. |
| HIPPO separation rule | Present in `04_HIPPO_SOURCE_CLOSURE.md` | Confirms HY and QBank must remain separate; no source-level closure evidence is supplied. |
| FRCEM duplicate lineage claim | Present in `05_FRCEM_SOURCE_CLOSURE.md` | Supports retention of the duplicate lineage claim; it does not close edition, rights, reviewer, or source identity. |
| Oxford identity warning | Present in `06_OXFORD_SOURCE_CLOSURE.md` | Correctly preserves identity uncertainty; no official edition evidence is supplied. |
| Medical review assignment | Template only; all listed statuses are `Pending` | No independent medical-review completion evidence. |
| Rights tracker | Present, with missing or pending statuses | No rights license, permission, owner statement, or display-scope evidence. |
| Closure gate | Present and explicitly incomplete | Confirms that required fields remain open. |
| Original source payloads and sidecars | Not present | No direct file/container verification for the listed families can be performed from this archive alone. |

## 3. Source-by-source evidence closure matrix

The “existing evidence” column distinguishes evidence contained in the closure package from previously recorded file-level evidence in the current SEG registry. Previously recorded evidence is not silently promoted to closure; it is included only to identify what remains missing. [2]

| Source | Evidence that exists | Missing evidence | Progression blocker |
|---|---|---|---|
| **Drug HTML** — `deepseek_html_20260615_a3266b.html` | The package records the artifact name, SHA-256 `5367711d08df2393cf852815b1b9d0ad4dac8240ac061cd88c71a53884e938ac`, and observed structure: 47 drug entities, 19 sections, 21 quick summaries, and 20 exam-trap entries. [3] The current registry independently records the same file-level checksum and treats it as a derived HTML artifact. [2] | Authoritative original source and exact source location; source version/edition; author, publisher, or owner; license or display permission; professional track and taxonomy; source-versioned locators; independent clinical reviewer and completed review decision; append-only audit evidence linking the derived HTML to the authoritative source. | The HTML is a derived clinical-claims artifact with no complete source envelope. It cannot progress to medication/reference import, content mapping, or clinical activation. Current gate remains `BLOCKED_PENDING_EXTERNAL_EVIDENCE_AND_MEDICAL_REVIEW`. |
| **OSCE Atlas** — `ATLAS_ASSET_OSCE_VISUAL_001` | The package identifies the requested container as `OSCE_Emergency_Medicine_Imaging_Section_Package.zip` and lists expected images, PNG assets, visual-validation notes, UTF-8 station text, SHA-256, size, archive path, lineage, and rights metadata. [4] The current registry records that the named container, 14-PNG package, and notes were not available for direct fingerprinting. [2] | The actual ZIP; complete member listing; all 14 PNGs; UTF-8 station text; `visual_validation_notes.txt`; container and per-file SHA-256; byte sizes and archive paths; source owner/version and exact provenance; image display rights; medical/visual review evidence; locators and audit trail. | Artifact recovery and independent verification are blocked. No Atlas record, content mapping, or N:M relationship may be created. The adjacent Internship OSCE framework and unrelated ZIP cannot substitute for this package. |
| **HIPPO HY** — `UPD811-005` | The closure package confirms that HIPPO HY must remain separate from the QBank and lists the required evidence fields. [5] The current registry has a file-level SHA `fe9b1df0eae11416195c919095aa946c80212ed48e3ef59f9c0a50e2db5eef5c` and records separate study-book lineage. [2] | Package-accessible source artifact or independently verifiable file identity; authoritative publisher/owner; edition and version; rights/display permission; exact locators; professional track/taxonomy; independent medical-review record; audit events connecting source identity, version, and representation. | The existing SHA and separation rule do not prove the official source identity, rights, edition, or medical approval. Progression remains `BLOCKED_PENDING_METADATA_AND_EXTERNAL_EVIDENCE`. |
| **HIPPO QBank** — `UPD811-002` | The package confirms separate treatment from HIPPO HY and requires SHA, file identity, lineage, publisher, edition, rights, and medical review. [5] The current registry has SHA `b9c1636f84f802d9f68794a3fa6f3d6ca34617fc08eda0a9ffb863262001771b` and structurally observed 1,927 question markers and 1,927 answer markers; these are not validated governed question units. [2] | Authoritative source identity and ownership; edition/version; rights and display permission; source-versioned question locators; taxonomy and explicit track; completed independent medical review; question/answer/explanation lineage audit; completeness evidence for all units. | Structural counts and a checksum do not close provenance, rights, or clinical-review gates. Progression remains `BLOCKED_PENDING_METADATA_AND_REVIEW`. HY and QBank must not be merged. |
| **Pretest** — `UPD811-007` | No Pretest-specific closure document or closure claim is present in the package. The current registry records SHA `b4ba84879b1247b9aaeb6172c6dffcb7dcc0860f8894e4651b2bc8a9fd669166` and a source-restoration blocker caused by visible OCR/extraction corruption. [2] | A source-specific closure record; restored authoritative representation; version/edition and source identity; publisher/owner; rights/display permission; exact locators; explicit track/taxonomy; independent medical review; restoration audit trail showing what representation is authoritative. | `REQUIRES_SOURCE_RESTORATION` is an immediate blocker. The package does not provide restoration evidence or any independent evidence that would permit downstream transformation. |
| **FRCEM study-book lineage** — `UPD811-001` / `UPD811-004` | The package records duplicate lineage and correctly states that edition, publisher, rights, and reviewer are required. [6] The current registry records both occurrences, confirms byte-identical text, and provides SHA `f5fb6b3f88b94a1b5a1a360acfe4616a5b3a5940a4b0854a35ba646f5f95a4a1` for both. [2] | Official source identity; edition/version; publisher/owner; license/display permission; independent medical reviewer and completed review; precise source-versioned locators; final duplicate/representation governance decision; audit evidence for retention without merge. | Duplicate lineage is evidence of identity relation, not permission to merge or import. Rights, version, and clinical-review gates remain open. |
| **FRCEM QBank** — `UPD811-003` | The current registry records a separate question/answer/explanation artifact with SHA `08d73b475a7ff1eda0cbbe905c5109628598b5210e8710ac0e8fae19dddad995` and 1,529 question and 1,529 answer markers. [2] The closure package does not provide a separate QBank closure record or its own review evidence. | Source identity, edition/version, publisher/owner, rights, question locators, explicit track/taxonomy, completeness and unit-lineage evidence, independent medical review, and audit trail. | The package does not close the QBank representation separately. It cannot be treated as covered by the study-book duplicate note. |
| **Oxford** — `Emergency_Oxford_Essentials.pdf` / `UPD811-008` | The package correctly warns that “Oxford” alone does not prove identity and requires ISBN, edition, publisher evidence, and license. [7] The current registry has SHA `353219418d900a27e48bb28c086965135451600e21ea5f8a98d5bfc508895be7`, but records that its title/metadata do not establish an official Oxford edition or ownership. [2] | ISBN; authoritative official edition; publisher/owner evidence; version; license/display permission; exact locators; professional track/taxonomy; independent medical review; provenance and audit linking the PDF to the claimed source. | Source identity and rights remain unresolved. Progression remains `BLOCKED_PENDING_SOURCE_IDENTITY_AND_RIGHTS`. |
| **Clinical Images** | The package’s general source-status table names provenance as the blocker and requires source, rights, and alt text. [1] | The package has no Clinical Images source-specific artifact, inventory, per-image SHA-256, owner/source/version, location, rights/display permission, alt-text record, medical/visual review, taxonomy/track, or audit evidence. The latest canonical source-status report does not provide a closed Clinical Images row. [2] | There is no verifiable image evidence to review. The family remains blocked; it must not be merged with OSCE Atlas or substituted with managed runtime assets. |

## 4. Cross-source missing-evidence register

The package supplies useful requests and blocker labels, but it does not provide the independent evidence needed to close the registry. The same unresolved categories recur across the source families:

| Missing evidence class | Affected sources | Closure requirement |
|---|---|---|
| Authoritative source identity and owner/publisher | Drug HTML, HIPPO HY, HIPPO QBank, Pretest, FRCEM, Oxford, Clinical Images | An independently verifiable source identity, not a filename, title signal, or preparer metadata. |
| Version, edition, or release label | All except none fully closed | Edition/version tied to the exact artifact and its SHA. |
| Rights and display permission | All listed families | License, permission, or rights record covering the intended SEG use and display scope. |
| Independent medical review | All medical content and images | Completed reviewer assignment/decision with specialty, scope, date, and audit evidence; templates marked Pending do not close this gate. |
| Precise locators | Drug HTML, HIPPO, Pretest, FRCEM, Oxford, OSCE, Clinical Images | Page, section, question ID, figure, station, or other source-versioned locator that can be reproduced. |
| Professional track and taxonomy | All source families | Explicit governed track/taxonomy; filenames and educational signals cannot assign Internship or Resident content. |
| Source-to-derivative lineage | Drug HTML, derived/question artifacts, image families | Evidence linking the derivative to the authoritative source/version without silently merging representations. |
| Append-only audit trail | All sources | Intake, review, rights, and decision events with immutable references. |

## 5. Progression decisions

No source reaches evidence closure in this package. The package should be retained as a **closure-worklist and evidence-request bundle**, not treated as a source registry approval artifact. In particular, a checksum by itself proves file identity only; it does not prove ownership, rights, version, clinical correctness, or approval.

The next allowed action is to collect the missing external evidence for each source, preserve every original artifact, fingerprint each accessible file, and append the evidence to a separate governed review package. Only after those gates are independently satisfied may the project proceed to a separately authorized structural/schema validation dry run. No content normalization, database mapping, adapter construction, import, activation, or learner exposure is authorized by this report.

## 6. Non-actions

- No source content was normalized, rewritten, translated, corrected, or clinically assessed.
- No source, representation, ZIP, image, or document was deleted, renamed, replaced, merged, or imported.
- No `SEG_CONTENT_RECORD_V1_1` object, mapping, adapter, Atlas record, or N:M link was created.
- No SQL, Prisma, seed, migration, Supabase change, database write, activation, publication, or Git operation was performed.
- No unresolved evidence was closed by inference or by omission.

## 7. Final status

> **`BLOCKED_PENDING_EVIDENCE`**

The evidence-closure review itself is complete, but the Source Registry is **not closed** because the package contains governance notes and requests rather than the missing authoritative source, rights, review, locator, provenance, and audit evidence.

## References

[1]: `/tmp/seg-source-registry-closure-inspection/ALL_TEXT.md` "Evidence Closure Package contents"

[2]: `/home/ubuntu/seg-internship-output/SEG_SOURCE_REGISTRY_STATUS_REPORT.md` "Current SEG Source Registry Status Report"

[3]: `/home/ubuntu/seg-internship-output/SEG_DRUG_HTML_SOURCE_REVIEW.md` "Drug HTML Source Review"

[4]: `/home/ubuntu/seg-internship-output/SEG_OSCE_ATLAS_SOURCE_REVIEW.md` "OSCE Atlas Source Review"

[5]: `/home/ubuntu/seg-internship-output/SEG_CONTENT_TRANSFER_MATRIX.md` "SEG Content Transfer Matrix"

[6]: `/home/ubuntu/seg-internship-output/SEG_PHASE_7_8_11_UPDATED_SOURCE_REGISTRY.md` "SEG Phase 7.8.11 Updated Source Registry"

[7]: `/tmp/seg-source-registry-closure-inspection/extracted/SEG_SOURCE_REGISTRY_EVIDENCE_CLOSURE_PACKAGE_v1.0/06_OXFORD_SOURCE_CLOSURE.md` "Oxford Source Closure document in the inspected package"

